- You can view the full Valeant Pharmaceuticals International Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Analysts blame drug companies, not pharmacy benefit managers, for the rising cost of drugs.
Siggi Olfasson is poised to step down as president and CEO of Teva's global generic medicines group by the end the first quarter of 2017.